Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity.
An important characteristic of tumors is that they at some point in their development overcome the surveillance of the immune system. Tumors secrete exosomes, multivesicular bodies containing a distinct set of proteins that can fuse with cells of the circulating immune system. Purified exosomes from TS/A breast cancer cells, but not non-exosomal fractions, inhibit (at concentrations of nanograms per ml protein) IL-2-induced natural killer (NK) cell cytotoxicity. The dietary polyphenol, curcumin (diferuloylmethane), partially reverses tumor exosome-mediated inhibition of natural killer cell activation, which is mediated through the impairment of the ubiquitin-proteasome system. Exposure of mouse breast tumor cells to curcumin causes a dose-dependent increase in ubiquitinated exosomal proteins compared to those in untreated TS/A breast tumor cells. Furthermore, exosomes isolated from tumor cells pretreated with curcumin have a much attenuated inhibition of IL-2 stimulated NK cell activation. Jak3-mediated activation of Stat5 is required for tumor cytotoxicity of IL-2 stimulated NK cells. TS/A tumor exosomes strongly inhibit activation of Stat5, whereas the tumor exosomes isolated from curcumin-pretreated tumor cells have a lowered potency for inhibition of IL-2 stimulated NK cell cytotoxicity. These data suggest that partial reversal of tumor exosome-mediated inhibition of NK cell tumor cytotoxicity may account for the anti-cancer properties of curcumin.
Zhang
Huang-Ge
HG
Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Huang-Ge.Zhang@ccc.uab.edu
Kim
Helen
H
Liu
Cunren
C
Yu
Shaohua
S
Wang
Jianhua
J
Grizzle
William E
WE
Kimberly
Robert P
RP
Barnes
Stephen
S
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism*; D001943:Breast Neoplasms / Q000276:immunology / Q000473:pathology; D045744:Cell Line, Tumor; D003474:Curcumin / Q000378:metabolism*; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D007107:Immune System / Q000502:physiology; D007376:Interleukin-2 / Q000276:immunology; D053616:Janus Kinase 3 / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology*; D051379:Mice; D009363:Neoplasm Proteins / Q000378:metabolism; D025801:Ubiquitin / Q000378:metabolism
D000970:Antineoplastic Agents; D007376:Interleukin-2; D009363:Neoplasm Proteins; D025801:Ubiquitin; D053616:Janus Kinase 3; D003474:Curcumin